Equity Overview
Price & Market Data
Price: $0.026
Daily Change: -$0.004 / 15.38%
Daily Range: $0 - $0
Market Cap: $2,760,417
Daily Volume: 0
Performance Metrics
1 Week: 23.22%
1 Month: 44.44%
3 Months: -25.71%
6 Months: -16.13%
1 Year: -48.00%
YTD: 30.00%
Details
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.